Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
5.61
+0.24 (4.47%)
Apr 25, 2025, 12:28 PM EDT - Market open

Emergent BioSolutions Market Cap

Emergent BioSolutions has a market cap or net worth of $304.83 million as of April 25, 2025. Its market cap has increased by 152.76% in one year.

Market Cap
304.83M
Enterprise Value
868.39M
1-Year Change
152.76%
Ranking
Category
Stock Price
$5.61

Market Cap Chart

Since November 15, 2006, Emergent BioSolutions's market cap has decreased from $320.80M to $304.83M, a decrease of -4.98%. That is a compound annual growth rate of -0.28%.

History

DateMarket Cap% Change
Apr 24, 2025291.80M-43.67%
Dec 31, 2024518.00M316.06%
Dec 29, 2023124.50M-78.87%
Dec 30, 2022589.20M-74.81%
Dec 31, 20212.34B-50.75%
Dec 31, 20204.75B70.50%
Dec 31, 20192.79B-7.78%
Dec 31, 20183.02B57.00%
Dec 29, 20171.92B44.63%
Dec 30, 20161.33B-14.64%
Dec 31, 20151.56B52.38%
Dec 31, 20141.02B22.29%
Dec 31, 2013836.10M45.38%
Dec 31, 2012575.10M-5.00%
Dec 30, 2011605.40M-25.67%
Dec 31, 2010814.50M94.58%
Dec 31, 2009418.60M-46.42%
Dec 31, 2008781.20M419.07%
Dec 31, 2007150.50M-50.82%
Dec 29, 2006306.00M-4.61%
View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 775.55B
UnitedHealth Group 375.22B
Johnson & Johnson 368.23B
AbbVie 320.57B
Novo Nordisk 276.96B
Abbott Laboratories 221.14B
AstraZeneca 215.41B
Novartis AG 210.89B
Market Cap Rankings